At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02659 BAO PHARMA-B
Not Yet Opened 08-12 16:08:06
17.100
+0.150
+0.88%
High17.190Low16.700Vol281.40K
Open17.010D1 Closing16.950Amplitude2.89%
Mkt Cap5.54BTradable Cap2.62BTotal Shares324.00M
T/O4.77MT/O Rate0.18%Tradable Shares153.00M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return Reporting Share Repurchase
Reuters  ·  07-28
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return Reporting Share Repurchase
BAO PHARMA-B (02659) Invests HKD 1.28 Million in Share Buyback on July 27
Stock News  ·  07-27
BAO PHARMA-B (02659) Invests HKD 1.28 Million in Share Buyback on July 27
BAO PHARMA-B Spends HK$1.99 Million to Repurchase 115,200 Shares on July 24
Deep News  ·  07-26
BAO PHARMA-B Spends HK$1.99 Million to Repurchase 115,200 Shares on July 24
Bao Pharma buys back 115,200 H-shares for HKD 1.99 million, trimming free float by 0.08%
Bulletin Express  ·  07-24
Bao Pharma buys back 115,200 H-shares for HKD 1.99 million, trimming free float by 0.08%
Shanghai Bao Pharma Files HKEX Next-day Return Disclosing Share Repurchase at HKD 17.31 Each
Reuters  ·  07-24
Shanghai Bao Pharma Files HKEX Next-day Return Disclosing Share Repurchase at HKD 17.31 Each
Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million
Bulletin Express  ·  07-23
Bao Pharma repurchases 112,300 H-shares; treasury stock rises to 1.48 million
Bao Pharma repurchases 110,900 H-shares; treasury stock climbs to 1.37 million
Bulletin Express  ·  07-22
Bao Pharma repurchases 110,900 H-shares; treasury stock climbs to 1.37 million
BAO PHARMA-B Repurchases 110.9 Thousand Shares for Approximately HK$2 Million on July 22
Stock News  ·  07-22
BAO PHARMA-B Repurchases 110.9 Thousand Shares for Approximately HK$2 Million on July 22
Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation
Reuters  ·  07-22
Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Repurchase for Cancellation
BAO PHARMA-B Allocates HK$1.99 Million for Share Buyback on July 20
Stock News  ·  07-20
BAO PHARMA-B Allocates HK$1.99 Million for Share Buyback on July 20
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure on Share Repurchase
Reuters  ·  07-20
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure on Share Repurchase
Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b
Simply Wall St.  ·  07-18
Insider Purchases Worth CN¥5.34m See Losses As Shanghai Bao Pharmaceuticals Market Value Drops To HK$5.6b
BAO PHARMA-B Repurchases Shares for HK$1.99 Million on July 17
Stock News  ·  07-17
BAO PHARMA-B Repurchases Shares for HK$1.99 Million on July 17
Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Buyback at HKD 17.71 Each
Reuters  ·  07-17
Shanghai Bao Pharmaceuticals Files HKEX Next-day Return Disclosing Share Buyback at HKD 17.71 Each
Bao Pharma Repurchases 100,300 H-Shares for HKD 1.99 Million, Lifting Treasury Stock to 1.04 Million Shares
Bulletin Express  ·  07-15
Bao Pharma Repurchases 100,300 H-Shares for HKD 1.99 Million, Lifting Treasury Stock to 1.04 Million Shares
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 19.88 Average Price
Reuters  ·  07-15
Shanghai Bao Pharmaceuticals Files HKEX Next-day Disclosure Return on Share Repurchase at HKD 19.88 Average Price
BAO PHARMA-B repurchases 101,700 H-shares for HK$1.99 million; treasury stock rises to 834,900 shares
Bulletin Express  ·  07-13
BAO PHARMA-B repurchases 101,700 H-shares for HK$1.99 million; treasury stock rises to 834,900 shares
Shanghai Bao Pharmaceuticals Files HKEX Disclosure Return on Share Repurchase
Reuters  ·  07-13
Shanghai Bao Pharmaceuticals Files HKEX Disclosure Return on Share Repurchase
BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10
Stock News  ·  07-10
BAO PHARMA-B Repurchases 149,800 Shares for HK$2.99 Million on July 10
Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity
Bulletin Express  ·  07-09
Bao Pharma Executes HKD 3.00 Million Share Buyback, Bringing Treasury Shares to 0.38% of Mandate Capacity
No data available

Introduction

Company Name.
BAO PHARMA-B
Affiliated Markets:
SEHK
Listing Date:
--
Main Business:
Shanghai Bao Pharmaceuticals Co Ltd is a China-based company principally engaged in research and development of pharmaceutical products. The Company leverages synthetic biology technology to develop and deliver recombinant biologic drugs, targeting conditions with limited treatment options and complex manufacturing challenges. The Company focuses on four areas, including large-volume subcutaneous drug delivery, antibody-mediated autoimmune conditions, drugs in assisted reproduction and recombinant biologic products as transformative alternative to traditional biochemical production. The Company’s Core Products comprise SJ02 (Slonva), a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP), KJ017, a recombinant human hyaluronidase, and KJ103, an innovative recombinant immunoglobulin G (IgG)-degrading enzyme.
Issue price:
--